CHC Healthcare Group (TPE:4164)
30.50
-0.20 (-0.65%)
Apr 24, 2026, 1:30 PM CST
CHC Healthcare Group Market Cap
CHC Healthcare Group has a market cap or net worth of 5.96 billion as of April 24, 2026. Its market cap has decreased by -32.39% in one year.
Market Cap
5.96B
Enterprise Value
9.93B
Revenue
4.40B
Ranking
n/a
PE Ratio
30.59
Stock Price
30.50
Market Cap Chart
Since October 18, 2011, CHC Healthcare Group's market cap has decreased from 9.89B to 5.96B, a decrease of -39.78%. That is a compound annual growth rate of -3.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 5.96B | -20.78% |
| Dec 31, 2025 | 7.52B | 7.82% |
| Dec 31, 2024 | 6.97B | -31.26% |
| Dec 29, 2023 | 10.15B | 44.21% |
| Dec 30, 2022 | 7.04B | 14.81% |
| Dec 30, 2021 | 6.13B | 3.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 240.14B |
| Caliway Biopharmaceuticals | 173.53B |
| Heron Neutron Medical | 65.21B |
| Lotus Pharmaceutical | 59.53B |
| Formosa Laboratories | 6.39B |
| Mycenax Biotech | 6.19B |
| Sinphar Pharmaceutical | 6.14B |
| AnnJi Pharmaceutical | 6.12B |